Researchers evaluated a rapid COVID-19 test at two community sites in Arizona.

Researchers conducted an evaluation study to see how well the Abbott BinaxNOW rapid antigen test worked for finding SARS-CoV-2, the virus that causes COVID-19. The study took place at two community-based testing sites in Pima County, Arizona, and involved people who came to those sites for testing. The specific results of the test's performance, such as its accuracy compared to other tests, were not reported in the available information. This means we do not know from this report how many cases it correctly identified or missed. The report also did not mention any safety concerns related to using the test. The main reason to be careful is that without the actual results, we cannot draw any conclusions about whether this test is a good option for community testing. This appears to be an early report that simply notes an evaluation was done. Readers should understand that this is not a complete study with findings they can use. It highlights that research is ongoing to check how tests work outside of controlled labs, but we need to wait for the full results to know more.